hey @flyboy77 wouldn't a CR 'dilute' the shares to some extent hence could be expect a small retract? if not, as you are saying, could I trouble you for a brief explanation behind your thought process? thanks in advance mate. Jay
NTI Neurotech knocked back by FDA as agency declares target condition not rare enough for special status
